NO985680L - Peptidderivater - Google Patents

Peptidderivater

Info

Publication number
NO985680L
NO985680L NO985680A NO985680A NO985680L NO 985680 L NO985680 L NO 985680L NO 985680 A NO985680 A NO 985680A NO 985680 A NO985680 A NO 985680A NO 985680 L NO985680 L NO 985680L
Authority
NO
Norway
Prior art keywords
peptide
Prior art date
Application number
NO985680A
Other languages
English (en)
Norwegian (no)
Other versions
NO985680D0 (no
Inventor
Ronald Cotton
Philip Neil Edwards
Richard William Arthur Luke
Keith Oldham
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9611881.5A external-priority patent/GB9611881D0/en
Priority claimed from GBGB9622890.3A external-priority patent/GB9622890D0/en
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Publication of NO985680D0 publication Critical patent/NO985680D0/no
Publication of NO985680L publication Critical patent/NO985680L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/825—Bacteria
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/85—Reproductive organs or embryos
    • Y10S530/851—Placenta; amniotic fluid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Rehabilitation Therapy (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
NO985680A 1996-06-07 1998-12-04 Peptidderivater NO985680L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9611881.5A GB9611881D0 (en) 1996-06-07 1996-06-07 Peptide derivatives
GBGB9622890.3A GB9622890D0 (en) 1996-11-02 1996-11-02 Peptide compounds
PCT/GB1997/001491 WO1997046578A1 (en) 1996-06-07 1997-06-03 Peptide derivatives

Publications (2)

Publication Number Publication Date
NO985680D0 NO985680D0 (no) 1998-12-04
NO985680L true NO985680L (no) 1999-02-04

Family

ID=26309459

Family Applications (1)

Application Number Title Priority Date Filing Date
NO985680A NO985680L (no) 1996-06-07 1998-12-04 Peptidderivater

Country Status (21)

Country Link
US (2) US6541453B2 (sk)
EP (1) EP0914333B1 (sk)
JP (1) JP2000512277A (sk)
KR (1) KR100451522B1 (sk)
CN (1) CN1130372C (sk)
AR (1) AR008389A1 (sk)
AT (1) ATE283278T1 (sk)
AU (1) AU727757B2 (sk)
BR (1) BR9709533A (sk)
CA (1) CA2252417A1 (sk)
DE (1) DE69731747T2 (sk)
HR (1) HRP970308B1 (sk)
ID (1) ID17440A (sk)
IL (1) IL127332A0 (sk)
NO (1) NO985680L (sk)
NZ (1) NZ332347A (sk)
PL (1) PL330348A1 (sk)
SK (1) SK166798A3 (sk)
TR (1) TR199802537T2 (sk)
TW (1) TW474947B (sk)
WO (1) WO1997046578A1 (sk)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9809021D0 (en) 1998-04-29 1998-06-24 Zeneca Ltd Chemical process
TR200201036T2 (tr) * 1999-10-18 2002-08-21 Akzo Nobel N.V. İmmünoterapide kullanmak için değiştirilmiş peptitler ve peptido-taklitleri
JP2008188285A (ja) * 2007-02-06 2008-08-21 Bridgestone Corp バックパッド及び車両用シート
EP2331571B1 (en) 2008-09-18 2015-08-26 Northwestern University Nmda receptor modulators and uses thereof
US8951968B2 (en) 2009-10-05 2015-02-10 Northwestern University Methods of treating depression and other related diseases
KR101692275B1 (ko) 2010-02-11 2017-01-04 노오쓰웨스턴 유니버시티 ２차 구조 안정화된 ｎｍｄａ 수용체 조절제 및 그의 용도
SG183265A1 (en) 2010-02-11 2012-09-27 Univ Northwestern Secondary structure stabilized nmda receptor modulators and uses thereof
EA201591404A1 (ru) 2013-01-29 2016-01-29 Аптиникс Инк. Спиролактамные модуляторы рецептора nmda и их применение
SI3514158T1 (sl) 2013-01-29 2023-03-31 Aptinyx Inc. Spirolaktamski modulatorji NMDA-receptorja in njihove uporabe
JP6531042B2 (ja) * 2013-01-29 2019-06-12 アプティニックス インコーポレイテッド スピロラクタム系ｎｍｄａ受容体モジュレーターおよびその使用
EA201591405A1 (ru) 2013-01-29 2017-05-31 Аптиникс Инк. Спиролактамные модуляторы nmda-рецептора и их применение
KR20150110787A (ko) 2013-01-29 2015-10-02 노렉스, 인크. 스피로-락탐 nmda 수용체 조절인자 및 그의 용도
WO2017201285A1 (en) 2016-05-19 2017-11-23 Aptinyx Inc. Spiro-lactam nmda receptor modulators and uses thereof
PE20190174A1 (es) 2016-05-19 2019-02-01 Aptinyx Inc Moduladores del receptor espiro-lactama n-metil-d-aspartato y usos de los mismos
BR112019001921A2 (pt) 2016-08-01 2019-05-14 Aptinyx Inc. moduladores do receptor nmda de espiro-lactama e seus usos
IL264496B (en) 2016-08-01 2022-09-01 Aptinyx Inc Spiro-lactam and bis-spiro-lactam nmda receptor modulators and uses thereof
WO2018026798A1 (en) 2016-08-01 2018-02-08 Aptinyx Inc. Spiro-lactam nmda modulators and methods of using same
US10918637B2 (en) 2016-08-01 2021-02-16 Aptinyx Inc. Spiro-lactam NMDA receptor modulators and uses thereof
CA3031537A1 (en) 2016-08-01 2018-02-08 Aptinyx Inc. Spiro-lactam nmda receptor modulators and uses thereof
AU2019215058A1 (en) 2018-01-31 2020-09-17 Aptinyx Inc. Spiro-lactam nmda receptor modulators and uses thereof
CN109115899A (zh) * 2018-06-19 2019-01-01 南京肽业生物科技有限公司 一种Fmoc氨基酸的分析方法
US12012413B2 (en) 2019-11-11 2024-06-18 Tenacia Biotechnology (Hong Kong) Co., Limited Methods of treating painful diabetic peripheral neuropathy
EP4141110A1 (en) 2020-04-24 2023-03-01 Obshchestvo S Ogranichennoy Otvetstvennost'yu "Ingenik" Method for producing particles of bacteriophages of the genus levivirus

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4301151A (en) 1979-11-27 1981-11-17 Merck & Co., Inc. Long-lasting agonists of enkephalin
US4254107A (en) 1979-11-27 1981-03-03 Merck & Co., Inc. Long-lasting agonists of enkephalin
US4474778A (en) 1983-11-09 1984-10-02 E. R. Squibb & Sons, Inc. Lactam containing compounds, their pharmaceutical compositions and method of use
US4680283A (en) 1984-09-26 1987-07-14 Merck & Co., Inc. Analogs of substance P and eledoisin
DE3711335A1 (de) 1987-04-03 1988-10-20 Merck Patent Gmbh Aminosaeurederivate
US5331089A (en) 1988-03-25 1994-07-19 Merck Sharpe & Dohme, Ltd. Peptides useful as tachykinin agonists
EP0360390A1 (en) 1988-07-25 1990-03-28 Glaxo Group Limited Spirolactam derivatives
JPH06504031A (ja) * 1988-09-30 1994-05-12 オーストレイリアン・コマーシヤル・リサーチ・アンド・デイベロツプメント・リミテツド アミノ酸輸送蛋白質、アミノ酸アナログ、アッセイ装置並びにその癌の治療及び診断への使用
US5223485A (en) 1989-01-31 1993-06-29 Abbott Laboratories Anaphylatoxin-receptor ligands
AU8305491A (en) 1990-08-01 1992-03-02 Cytel Corporation Novel immunosuppressant peptides
DE4034829A1 (de) 1990-11-02 1992-05-07 Merck Patent Gmbh Cyclopeptide
AU2468392A (en) 1991-08-29 1993-04-05 Cytel Corporation Novel immunosuppressants
ES2122145T3 (es) 1993-06-04 1998-12-16 Vertex Pharma Fosfiniloximetil-cetonas peptidicas como inhibidores de la enzima convertida de la interleuquina-1 beta.
JP3926839B2 (ja) 1993-09-14 2007-06-06 エピミューン，インコーポレイティド 万能ｄｒ−結合性ペプチドを用いる免疫応答の改変
AU2238395A (en) * 1994-04-01 1995-10-23 Immulogic Pharmaceutical Corporation Haptenated peptides and uses thereof
CA2215720A1 (en) 1995-03-24 1996-10-03 Molecumetics, Ltd. .beta.-sheet mimetics and use thereof as inhibitors of biologically active peptides or proteins
US5817757A (en) 1995-10-30 1998-10-06 Merck & Co., Inc. Inhibitors of peptide binding to MHO class II proteins
AU7604196A (en) 1995-10-30 1997-05-22 Merck & Co., Inc. Novel inhibitors of peptide binding to mhc class ii proteins
US5840835A (en) 1995-10-30 1998-11-24 Merck & Co., Inc. Inhibitors of peptide binding to MHC class II proteins
US5719296A (en) 1995-10-30 1998-02-17 Merck & Co., Inc. Pseudopeptide lactam inhibitors of peptide binding to MHC class II proteins
GB9702377D0 (en) 1996-02-23 1997-03-26 Zeneca Ltd Peptide derivatives
GB9621836D0 (en) 1996-10-19 1996-12-11 Zeneca Ltd Peptide compounds
GB9625865D0 (en) 1996-12-12 1997-01-29 Zeneca Ltd Peptides

Also Published As

Publication number Publication date
CN1221424A (zh) 1999-06-30
KR20000016465A (ko) 2000-03-25
NO985680D0 (no) 1998-12-04
EP0914333A1 (en) 1999-05-12
AR008389A1 (es) 2000-01-19
JP2000512277A (ja) 2000-09-19
ATE283278T1 (de) 2004-12-15
CA2252417A1 (en) 1997-12-11
US20020103335A1 (en) 2002-08-01
HRP970308A2 (en) 1998-04-30
AU2972097A (en) 1998-01-05
EP0914333B1 (en) 2004-11-24
US6541453B2 (en) 2003-04-01
AU727757B2 (en) 2000-12-21
HRP970308B1 (en) 2002-04-30
TR199802537T2 (xx) 1999-03-22
SK166798A3 (en) 1999-07-12
KR100451522B1 (ko) 2004-12-08
PL330348A1 (en) 1999-05-10
DE69731747D1 (de) 2004-12-30
CN1130372C (zh) 2003-12-10
WO1997046578A1 (en) 1997-12-11
ID17440A (id) 1997-12-24
BR9709533A (pt) 1999-08-10
NZ332347A (en) 2000-05-26
US20030195158A1 (en) 2003-10-16
IL127332A0 (en) 1999-09-22
DE69731747T2 (de) 2006-02-02
TW474947B (en) 2002-02-01

Similar Documents

Publication Publication Date Title
ATE208395T1 (de) Thiophenopyrimidine
NO985680D0 (no) Peptidderivater
ATE262512T1 (de) Arylalkanoylpyridazine
ATE208773T1 (de) Chinoxalindione
NO983849L (no) Peptidderivater
BR9508433A (pt) Peptídeos
DK0832553T3 (da) Mejetærsker
ATE353652T1 (de) Östroprogestatives antikonzeptionsmittel
TR199701666A3 (tr) Sismanliga karsi proteinler
BR9606756A (pt) Peptídeo
NO981052D0 (no) Peptidderivater
ATE235511T1 (de) Vielfältig verzweigte peptidkonstruktionen
NO981051D0 (no) Peptidderivater
DK1017798T3 (da) Lunasinpeptider
NO20000976D0 (no) Peptider
SE9504467D0 (sv) Peptide
BR1100812A (pt) Peptìdeo
ATE267568T1 (de) Epithese
ID17224A (id) Sediaan
BR7601509U (pt) Gafa
BR7603088U (pt) Kitgeométrico
BR7600429U (pt) Hidrolax
BR7601310U (pt) Microlivro
BR7601419U (pt) Mourao
BR7601508U (pt) Cogafa

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application